Skip to main content

Table 2 Background of aged patients and younger conterpart

From: Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older

     Aged (80-)   Control (-79)  
     (N = 21)   (N = 226)  
Age Age Median (Range)   81 (80-89)   56 (18-79)  
Gender Male    9 (43%) 101 (45%)
  Female    12 (57%) 125 (55%)
T classification T1    2 (10%) 30 (13%)
  T2    14 (67%) 146 (65%)
  T3    5 (24%) 50 (22%)
  Long diameter (mm)   30 ± 8   26 ± 9  
  Short diameter (mm)   18 ± 7   18 ± 8  
  Thickness (mm)   11 ± 6   9 ± 6  
Source Ra-226    4 (19%) 72 (32%)
  Ir-192    12 (71%) 120 (63%)
  Au-198    1 (5%) 0 (0%)
  MS-HDR    4 (19%) 34 (15%)
External radiotherapy Brachytherapy only    13 (80%) 165 (73%)
  Combined with external radiotherapy   8 (20%) 61 (27%)
Prescribed dose Brachytherapy Median (Range)(Gy) LDR 70 (54-85)   70 (50-112)  
    HDR 54 (32-60)   60 (42-60)  
  External radiotherapy Median (Range)(Gy) LDR   30 (12-60)  
  1. HDR; high dose rate, LDR; low dose rate